Michigan Compiled Laws
368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)
Section 333.17766f - Possession of Products Containing Ephedrine or Pseudoephedrine; Prohibited Conduct; Exceptions; Violation; Penalty; Affirmative Defense; Rebuttal; Conflict of Local Requirements With Section.

Sec. 17766f.
(1) A person who possesses products that contain any compound, mixture, or preparation containing any detectable quantity of ephedrine or pseudoephedrine, a salt or optical isomer of ephedrine or pseudoephedrine, or a salt of an optical isomer of ephedrine or pseudoephedrine for retail sale under a license issued under the general sales tax act, 1933 PA 167, MCL 205.51 to 205.78, shall not knowingly do any of the following:
(a) Sell any product described under this subsection to an individual under 18 years of age.
(b) Sell more than 3.6 grams of ephedrine or pseudoephedrine alone or in a mixture to any individual on any single calendar day.
(c) Sell more than 9 grams of ephedrine or pseudoephedrine alone or in a mixture to any individual within a 30-day period.
(d) Sell in a single over-the-counter sale more than 2 personal convenience packages containing 2 tablets or capsules each of any product described under this subsection to any individual.
(e) Sell any product described under this subsection to an individual during the period in which a stop sale alert is generated for that individual based upon criminal history record information provided under the methamphetamine abuse reporting act. The NPLEx system shall contain an override function that may be used by a dispenser of ephedrine or pseudoephedrine who has a reasonable fear of imminent bodily harm if the dispenser does not complete a sale. Each instance in which the override function is utilized shall be logged by the system.
(2) This section does not apply to the following:
(a) A pediatric product primarily intended for administration to children under 12 years of age according to label instructions.
(b) A product containing pseudoephedrine that is in a liquid form if pseudoephedrine is not the only active ingredient.
(c) A product that the state board of pharmacy, upon application of a manufacturer or certification by the United States drug enforcement administration as inconvertible, exempts from this section because the product has been formulated in such a way as to effectively prevent the conversion of the active ingredient into methamphetamine.
(d) A product that is dispensed pursuant to a prescription.
(3) A person who violates this section is responsible for a state civil infraction as provided under chapter 88 of the revised judicature act of 1961, 1961 PA 236, MCL 600.8801 to 600.8835, and may be ordered to pay a civil fine of not more than $500.00 for each violation.
(4) It is an affirmative defense to a citation issued under subsection (1)(a) that the defendant had in force at the time of the citation and continues to have in force a written policy for employees to prevent the sale of products that contain any compound, mixture, or preparation containing any detectable quantity of ephedrine or pseudoephedrine, a salt or optical isomer of ephedrine or pseudoephedrine, or a salt of an optical isomer of ephedrine or pseudoephedrine to persons under 18 years of age and that the defendant enforced and continues to enforce the policy. A defendant who proposes to offer evidence of the affirmative defense described in this subsection shall file and serve notice of the defense, in writing, upon the court and the prosecuting attorney. The notice shall be served not less than 14 days before the hearing date.
(5) A prosecuting attorney who proposes to offer testimony to rebut the affirmative defense described in subsection (4) shall file and serve a notice of rebuttal, in writing, upon the court and the defendant. The notice shall be served not less than 7 days before the hearing date and shall contain the name and address of each rebuttal witness.
(6) Notwithstanding any other provision of law, a city, township, village, county, other local unit of government, or political subdivision of this state shall not impose any new requirement or prohibition pertaining to the sale of a product described under subsection (1) that is contrary to, or in any way conflicting with, this section. This subsection does not invalidate or otherwise restrict a requirement or prohibition described in this subsection existing on December 15, 2005.
History: Add. 2005, Act 86, Imd. Eff. July 20, 2005 ;-- Am. 2011, Act 86, Imd. Eff. July 15, 2011 ;-- Am. 2014, Act 275, Eff. Jan. 1, 2015 Popular Name: Act 368

Structure Michigan Compiled Laws

Michigan Compiled Laws

Chapter 333 - Health

Act 368 of 1978 - Public Health Code (333.1101 - 333.25211)

Article 15 - Occupations (333.16101...333.18838)

368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)

Section 333.17701 - Meanings of Words and Phrases; General Definitions and Principles of Construction.

Section 333.17702 - Definitions; a to C.

Section 333.17703 - Definitions; D, E.

Section 333.17704 - Definitions; F to I.

Section 333.17705 - Definitions; L.

Section 333.17706 - Definitions; M, O.

Section 333.17707 - Definitions; P.

Section 333.17708 - Definitions; P to R.

Section 333.17708.amended - Definitions; P to R; Limitation on Prescription of Pharmacological Agents.

Section 333.17709 - Definitions; S to W.

Section 333.17711 - Practice of Pharmacy or Pharmacy Technician; License or Authorization Required; Use of Words, Titles, or Letters.

Section 333.17713 - Temporary Regulations of Pharmacists and Prescriptions During Qualified Order or Declaration; Definitions.

Section 333.17721 - Michigan Board of Pharmacy; Creation; Membership; Terms.

Section 333.17722 - Michigan Board of Pharmacy; Duties Generally.

Section 333.17723 - Pilot Project to Maintain or Improve Patient Care in Delivery of Pharmacy Services and Improving Patient Outcomes.

Section 333.17726 - Certificate of Licensure; Issuance.

Section 333.17731 - Renewal of Pharmacist or Pharmacy Technician License; Continuing Education; Rules.

Section 333.17733 - Relicensure of Pharmacist; Requirements.

Section 333.17737 - Rules Establishing Standards for Internship Program; Limited License Required.

Section 333.17739 - Pharmacy Technician; Functions; Licensure.

Section 333.17739a - Pharmacy Technician; Licensure; Requirements; Exemption From Certain Requirements.

Section 333.17739b - Pharmacy Technician; Temporary License.

Section 333.17739c - Pharmacy Technician; Limited License.

Section 333.17741 - Pharmacy License Required; Personal Charge of Pharmacy by Pharmacist; Responsibility for Compliance With Laws; Control and Personal Charge of Pharmacy Services; Remote Pharmacy Exception; Effect of Violation on Pharmacy License.

Section 333.17742 - Disclosure; "Applicant" Defined.

Section 333.17742a - Remote Pharmacy; Operation; Licensure Requirements; Location Waiver; Exception.

Section 333.17742b - Staffing of Remote Pharmacy; Requirements; Written Policy and Procedure Manual; Public Notice Display; Operation Requirements and Limitations; "Qualified Pharmacy Technician" Defined.

Section 333.17743 - Pharmacy License; Contents; Duration.

Section 333.17744 - Designation of Agent by Prescriber; Issuance of Prescription; Limitation; Transmission of Prescription to Pharmacy.

Section 333.17744a - Auto-Injectable Epinephrine; Prescribing or Issuing to Authorizing Entity.

Section 333.17744b - Prescribing, Possessing, or Dispensing Opioid Antagonist; Liability.

Section 333.17744c - Person Administering Opioid Antagonist Under Certain Conditions; Immunity From Criminal Prosecution or Sanction.

Section 333.17744d - Auto-Injectable Epinephrine; Storage, Maintenance, General Oversight, and Use by Designated Employee or Agent; Training Program; Certificate; Liability; Report; Administration by Person Other Than Employee, Agent, or Individual D...

Section 333.17744e - Dispensing Opioid Antagonist to Individual Pursuant to Standing Order Issued by Chief Medical Executive; "Community-Based Organization" Defined.

Section 333.17744f - Dispensing Emergency Supply of Insulin; Requirements; Limitation; Liability; Rules; Definitions.

Section 333.17745 - Drug Control License; Patient's Chart or Clinical Record to Include Record of Drugs Dispensed; Delegating Authority to Dispense Drugs; Storage of Drugs; Container; Label; Complimentary Starter Dose Drug; Information; Compliance Wi...

Section 333.17745a - Definitions; Public Health Program Without On-Site Pharmacy; Individuals Delegated Authority to Dispense Prescriptions; Delegating Delivery of Certain Oral Contraceptives; Circumstances; Delegating Delivery of Methadone.

Section 333.17745b - Industrial Clinic or Prescriber Practice Without On-Site Pharmacy; Dispensing Prescription Drug.

Section 333.17746 - Hospice Emergency Care Services in Patients' Homes; Medication Box Exchange Program.

Section 333.17747 - Drug Control License; Contents; Duration; Renewal; Conditions; License as Automatically Void.

Section 333.17748 - Pharmacy, Manufacturer, Wholesale Distributor; or Wholesale Distributor-Broker, License Required; Compounding Services; Renewal; Designation of Pharmacist in Charge; Joint Responsibility; Exemption; Report of Change in Ownership,...

Section 333.17748a - Compounding Services for Sterile Pharmaceuticals; Accreditation; Notification of Complaint; Maintenance and Retention of Records; Resale of Excess Compounded Pharmaceuticals Prohibited; Distribution of Samples or Complimentary St...

Section 333.17748b - Compounding Nonsterile or Sterile Pharmaceuticals for Prescriber or Health Facility or Agency to Administer to Patients Without Prescription; Authorization; Report of Adverse Event; List of Authorized Pharmacies and Pharmacists;...

Section 333.17748c - Compounding Pharmaceutical; Commercial Availability.

Section 333.17748d - Violation of MCL 333.17748a or 17748b; Penality.

Section 333.17748e - Out-of-State Pharmacy; Facilitation of Delivery or Trade; Use of Wholesale Distributor-Broker; Requirements; Liability; License Requirements; Transaction Records; Notification; Investigation; Definitions.

Section 333.17748f - Licensure of a Pharmacy as a Wholesale Distributor or Manufacturer; Requirements.

Section 333.17749 - Dispensing of Diagnostic or Therapeutic Pharmaceutical Agents by Wholesale Distributor or Pharmacist to Optometrist; Condition; “Therapeutic Pharmaceutical Agent” and “Diagnostic Pharmaceutical Agent” Defined.

Section 333.17750 - Person Who Distributes Complimentary Starter Doses to Prescribers; Records; Access by Board; “Complimentary Starter Dose” Defined.

Section 333.17750a - Dispensing of Prescription for Therapeutic Pharmaceutical Agent by Pharmacist.

Section 333.17751 - Dispensing Prescription Drug or Device Requiring Prescription; Requirements; Exception.

Section 333.17751.amended - Dispensing Prescription Drug or Device Requiring Prescription; Requirements; Exceptions.

Section 333.17752 - Prescription or Equivalent Record; Preservation; Disclosure; Providing Copies; Refilling Copy; Applicability of Subsection (3) to Pharmacies Sharing Real-Time, On-Line Database and Remote Pharmacies; "Equivalent Record" Defined.

Section 333.17753 - Centralized Prescription Processing; Conditions for Performing or Contracting; Maintenance of Policy and Procedures Manual; Definition.

Section 333.17754 - Electronic Transmission of Prescription; Conditions; Information; Confidentiality; Professional Judgment as to Accuracy, Validity, and Authenticity; Original Prescription; Inapplicable After October 1, 2021.

Section 333.17754a - Electronic Transmission of Prescription; Conditions; Information; Confidentiality; Professional Judgment as to Accuracy, Validity, and Authenticity; Exceptions; Waiver; Rules; Delayed Implementation.

Section 333.17755 - Dispensing Lower Cost Generically Equivalent Drug Product or Interchangeable Biological Drug Product; Notice; Contents of Prescription Label; Limitation; Restrictions; Limitation on Total Charge; Communication to Be Provided Presc...

Section 333.17756 - Label on Prescription; Contents.

Section 333.17757 - Price Information; Prohibited Conduct; Notice; Receipt Evidencing Transactions; Omission; Retention of Copy of Receipt; Rules.

Section 333.17757a - Providing Selling Price of Drugs Dispensed Upon Request; Notice to Consumers About Prescription Drugs; Contents; Form; Display; Copies.

Section 333.17757b - Contracts With Pharmacy Benefit Managers; Prohibited Terms.

Section 333.17758 - Repealed. 1986, Act 304, Eff. Mar. 31, 1987.

Section 333.17759 - Dispensing Harmful Drug; Requirements.

Section 333.17760 - Operation of Automated Device Not Located at Same Address as Pharmacy; Control and Supervision by Pharmacist; Delegation of Tasks.

Section 333.17761 - Display of Notice; Dispensing Prescription in Safety Closure Container.

Section 333.17762 - Misbranded Prescription.

Section 333.17763 - Grounds for Fine, Reprimand, or Probation; Grounds for Denying, Limiting, Suspending, or Revoking License.

Section 333.17764 - Conduct Constituting Misdemeanor; Violation; Penalty; Other Violations.

Section 333.17765 - Adulteration or Misbranding; Guaranty or Undertaking as Protection Against Penalties for Violation; Exception; Notice to Seller, Manufacturer, or Wholesale Distributor.

Section 333.17766 - Additional Conduct Constituting Misdemeanor.

Section 333.17766a - Repealed. 2001, Act 236, Imd. Eff. Jan. 3, 2002.

Section 333.17766b - Repealed. 2001, Act 231, Eff. Jan. 6, 2003.

Section 333.17766c - Purchase or Possession of Ephedrine or Pseudoephedrine or Mixture Prohibited; Violation; Penalty; Exceptions.

Section 333.17766d - Pharmacy Operated by Department of Corrections or Under Contract With County Jail; Resale or Redistribution of Prescription Drug; Definitions.

Section 333.17766e - Sale of Ephedrine or Pseudoephedrine; Requirements of Retail Distributor; Exceptions; Violation; Fine; Report.

Section 333.17766f - Possession of Products Containing Ephedrine or Pseudoephedrine; Prohibited Conduct; Exceptions; Violation; Penalty; Affirmative Defense; Rebuttal; Conflict of Local Requirements With Section.

Section 333.17766g - Sale, Trade, or Purchase of Dextromethorphan to Minor; Prohibition; Exception for Valid Prescription; Preemption; Violation; Civil Infraction and Fine.

Section 333.17767 - Rules and Determinations as to Licensing.

Section 333.17768 - Grounds for Fine, Reprimand, or Probation, or for Denying, Limiting, Suspending, or Revoking License or Ordering Restitution or Community Service; Applicability of Subsection (2)(b).

Section 333.17770 - Exceptions.

Section 333.17775 - "Program for Utilization of Unused Prescription Drugs"; Definitions; Unused Prescription Drug Repository and Distribution Program; Rules; Standards and Procedures.

Section 333.17776 - Destruction and Disposal of Certain Drugs and Medications.

Section 333.17780 - Cancer Drug Repository Program.